Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Kymera Therapeutics (KYMR) Other Gross PP&E Adjustments (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 27.04% to $20.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.9 million, a 27.04% increase, with the full-year FY2025 number at $20.9 million, up 27.04% from a year prior.
  • Other Gross PP&E Adjustments was $20.9 million for Q4 2025 at Kymera Therapeutics, down from $22.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $22.4 million in Q3 2025 to a low of -$33.7 million in Q1 2023.
  • A 5-year average of $5.4 million and a median of $7.6 million in 2022 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 763.15% in 2023, then soared 826.25% in 2024.
  • Kymera Therapeutics' Other Gross PP&E Adjustments stood at $5.0 million in 2021, then soared by 88.68% to $9.3 million in 2022, then crashed by 81.01% to $1.8 million in 2023, then skyrocketed by 826.25% to $16.4 million in 2024, then grew by 27.04% to $20.9 million in 2025.
  • Per Business Quant, the three most recent readings for KYMR's Other Gross PP&E Adjustments are $20.9 million (Q4 2025), $22.4 million (Q3 2025), and $19.3 million (Q2 2025).